Medication-assisted Treatment Waiver Training

Medication-assisted Treatment Waiver Training

Providers seeking approval to offer medication-assisted treatment for opioid use disorder can choose from two upcoming opportunities to get required training.

Choose a session Friday, Sept. 25, Saturday, Sept. 26, or Friday, Dec. 11, 2020, at the Norton Healthcare Learning Center, 9500 Ormsby Station Road in Louisville.

Registration

There is no fee for this program, but preregistration is required. Due to COVID-19 social distancing requirements, there will be limited seating at this event. Please register in advance to ensure a spot.

To register

  1. Visit NortonCME.com and select this activity.
  2. Call (502) 629-1234, option 4.
  3. Scan the QR code:

The Sessions

Overview

Medication-assisted treatment (MAT) of substance use disorders involves a combination of a medication that targets the brain and psychosocial interventions, such as counseling and skills development, aimed at improving treatment outcomes. Research shows that medications and therapy together may be more successful than either treatment method alone.

The U.S. Food and Drug Administration has approved three medications for the treatment of opioid use disorder. This course will provide the eight hours of training required for physicians to apply for the waiver from the U.S. Drug Enforcement Administration to prescribe one of those medications. Advanced practice providers who attend this program will be required to complete an additional 16 hours of MAT training.

Target Audience

This program is for physicians, nurse practitioners and physician assistants who wish to apply for a waiver to prescribe buprenorphine for the treatment of opioid use disorder, as well as those interested in learning more about MAT.

Speaker

Kelly Cooper, M.D., MPH
Medical Director
Addiction Services
Norton Behavioral Medicine

Educational Objectives

  1. Screen and identify patients with opioid use disorder (OUD) and define evidence-based treatments.
  2. Discuss the pharmacology of opioids as it relates to treatment of OUD patients.
  3. Describe the fundamentals of office-based opioid treatment, including the treatment of the co-morbid patient.
  4. Explain the process of buprenorphine induction as well as stabilization and maintenance.
  5. Discuss all FDA-approved antagonist and agonist medications to treat OUD.
  6. Discuss basic office protocols, including medical record documentation and confidentiality.
  7. Utilize evidence-based resources to ensure providers have the confidence to prescribe buprenorphine for patients with OUD.
  8. Recognize the importance of obtaining a waiver to begin treating patients with OUD.

Continuing Education

Joint Accreditation Statement: In support of improving patient care, this activity has been planned and implemented by the American Academy of Addiction Psychiatry and Norton Healthcare. The American Academy of Addiction Psychiatry is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credential Center (ANCC) to provide continuing education for the health care team.

In 2019, AAAP also added accreditation from The American Academy of PAs (AAPA), American Psychological Association (APA) and Association for Social Work Boards (ASWB).

Interprofessional Continuing Education (IPCE) Designation Statement: This activity was planned by and for the health care team, and learners will receive 8 (eight) Interprofessional Continuing Education credits for learning and change.

Physician Designation Statement: American Academy of Addiction Psychiatry designates this live activity for a maximum of 8 (eight) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Designation Statement: American Academy of Addiction Psychiatry is an approved provider of nursing continuing education through AAAP’s Joint Accreditation provider #4008192. This program is approved for up to 8 Nursing Contact Hours.

PA Designation Statement: American Academy of Addiction Psychiatry has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for a maximum of 8 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

House Bill 1 Credits

The Medication-assisted Treatment (MAT) Waiver Training has been approved for 4.5 HB1 credit hours by the Kentucky Board of Medical Licensure, ID #1119-H4.5-NHC5c. For information related to credits, contact the Norton Healthcare Center for Continuing Medical Education at (502) 446-5955 or cme@nortonhealthcare.org.